Mumbai: In a shocking study published in medical journal, The Lancet, scientists have found that one-third of malaria medicines in South East Asia and Africa are either fake or of poor quality. What is even worse is that a majority of these fake medicines are being manufactured in India and China. According to teh World Health Organisation (WHO), 2,500 people die worldwide every day of malaria. The Lancet study says ...
01:14 PM, May 24, 2012
Mumbai: In a shocking study published in medical journal, The Lancet, scientists have found that one-third of malaria medicines in South East Asia and Africa are either fake or of poor quality. What is even worse is that a majority of these fake medicines are being manufactured in India and China. According to teh World Health Organisation (WHO), 2,500 people die worldwide every day of malaria. The Lancet study says...
01:14 PM, May 24, 2012
New Delhi: A new study by UK-based medical journal Lancet has found that seven per cent of anti-malarial drugs tested in India are of poor quality and many are fake. The study goes on to say that 1 in every 3 anti-malarial drugs sold in southeast Asia are also fake. Researchers analysed data based on 1400 drug samples in five classes from seven Southeast Asian countries to reach to this...
10:11 AM, May 23, 2012
Health Minister Ghulam Nabi Azad said the new Malaria drug is efficacius and safe as its a synthetic moelcue there will be no problem in production too. ...
10:04 AM, Apr 26, 2012
Mumbai: By the time you're done watching this report, somewhere in the world - a child would have succumbed to malaria. A public health disaster in sub-Saharan Africa and parts of South East Asia, Malaria poses a threat to a 100 crore Indians, according to the latest World Malaria Report. About 1.5 million people suffer from malaria annually. A study published in the medical journal The Lancet, finds cases of...
10:14 AM, Apr 25, 2012
London: Malaria kills over 1.2 million people every year worldwide, twice as many deaths as thought earlier, while deaths from the mosquito-borne disease in India could be more than 45 times higher than what is currently estimated, a new study has claimed. Researchers at the University of Washington's Institute of Health Metrics and Evaluation who collected data on malaria deaths from 1980 to 2010 found that 1.2 million people died...
05:17 PM, Feb 03, 2012
New Delhi: 2011 was a year not just of landmark political revolutions but also of medical marvels. Be it HIV prevention or a vaccine for malaria, 2011 saw many medical breakthroughs. Here's a look at the top five: HIV treatment as prevention: It has been deemed as the most important scientific breakthrough of the year 2011. A study published in the journal Science this year, found that the same drugs...
08:45 AM, Dec 29, 2011
Mumbai: The world's first malaria vaccine is in its final stages of clinical trials. It's proving to be 56 per cent effective, which means it will reduce the risk of the disease by more than half. After 30 years of research, this is the best shot for a malaria vaccine. Two-year-old Philip is one of 15,000 African children taking part in a phase 3 trial. An earlier phase 2 trial...
09:07 AM, Oct 25, 2011
![]()
It's a eureka moment for scientists ... Experts have made a breakthrough with a malaria Vaccine being clinically tested in Africa right now. The new ...
11:57 AM, Oct 24, 2011
New Delhi: It is that time of the year when dengue and malaria cases are at its peak. The worst hit this time have been Gujarat and Hyderabad. Mosquito maladies malaria and dengue have hit Ahmedabad with 9,392 cases of malaria reported, against more than 5,900 cases from last year. There have been more than 450 cases of dengue as well. So far this year, 63 people in Ahmedabad have...
04:24 PM, Oct 19, 2011
London: An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease. Final-stage trial data released on Tuesday showed it gave protection against clinical and severe malaria in five- to 17-month-olds in Africa, where the mosquito-borne disease kills hundreds of thousands of children a year. "These data bring us to...
03:03 AM, Oct 19, 2011
Seattle: Nearly a third of all malaria affected countries are on course to eliminate the mosquito-borne disease over the next 10 years, the World Health Organisation (WHO) said on Monday. In a progress report published by the Roll Back Malaria (RBM) partnership at the start of an international Malaria Forum conference in Seattle, the United Nations health body said "remarkable progress" had been made. Up to a third of the...
04:16 AM, Oct 18, 2011
New Delhi: It's the season when academics take precedence, new chapters begin and lessons are learnt. But it seems some educational institutions have failed to do the latter. Because, with the onset of monsoons have arrived vector-borne diseases like malaria, dengue etc. On Monday, the Municipal Corporation of Delhi (MCD) found various educational institutions like Jawaharlal Nehru University (JNU), IIT Delhi and National Institute of Health and Family Welfare of...
04:45 PM, Jul 27, 2011
New Delhi: Researchers have claimed that they are very close to developing an anti-malaria vaccine. Almost 15,000 African children are participating in the phase three trials for the initiative. Two-year-old Philip Ouma is getting a shot that could transform the fight against malaria. He is one of the 15,000 African children participating in the phase three trial of a vaccine called Rts,s. Thirty years in development, it is the farthest...
09:22 AM, Jul 18, 2011
Mumbai has seen a four-fold increase in rain-related diseases, while Municipal records show total apathy in health issues. ...
08:59 AM, Jul 08, 2011
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
